Ether

Ether

SCHEMBL2582345

CCN.CCOCC

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL1092093 0.87
Ether SCHEMBL23611026 0.86
Ether SCHEMBL5492495 0.86
Ether SCHEMBL6 0.85
Ether SCHEMBL9248674 0.85 ALDH1A1 (0.47)
Ether SCHEMBL9248046 0.85 ALDH1A1 (0.47)
Ether SCHEMBL8160191 0.85 ALDH1A1 (0.47)
Ether SCHEMBL21406 0.85 ALDH1A1 (0.47)
Ether SCHEMBL1193753 0.84
Ether SCHEMBL11497999 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112795192-A High-strength flame-retardant polyphenylene sulfide engineering plastic and preparation method thereof 南京逸科景润科技有限公司 2021-05-14 CN claimed
CN-110669346-A Asphalt composite flame retardant and application thereof 四川科路泰交通科技有限公司 2020-01-10 CN claimed
US-20190263750-A1 IN VIVO GELLING PHARMACEUTICAL PRE-FORMULATION THERAGENICS CORPORATION 2019-08-29 US claimed
EP-2846847-A1 BIOCOMPATIBLE HYDROGEL TREATMENTS FOR RETINAL DETACHMENT Medicus Biosciences LLC (US) 2015-03-18 EP claimed
WO-2013170195-A1 BIOCOMPATIBLE HYDROGEL TREATMENTS FOR RETINAL DETACHMENT MEDICUS BIOSCIENCES, LLC (US) 2013-11-14 WO claimed
US-20130116341-A1 IN-VIVO GELLING PHARMACEUTICAL PRE-FORMULATION MEDICUS BIOSCIENCES, LLC (US) 2013-05-09 US claimed
WO-2011140519-A2 IN VIVO GELLING PHARMACEUTICAL PRE-FORMULATION MEDICUS BIOSCIENCES, LLC (US) 2011-11-10 WO claimed
US-20230218799-A1 BIOCOMPATIBLE HYDROGEL TREATMENTS FOR RETINAL DETACHMENT AQUARIAN CREDIT FUNDING LLC 2023-07-13 US disclosed
EP-2968680-B1 SOLID POLYGLYCOL-BASED BIOCOMPATIBLE PRE-FORMULATION C P MEDICAL CORP (US) 2023-05-03 EP disclosed
US-11596710-B2 Biocompatible hydrogel treatments for retinal detachment AQUARIAN CREDIT FUNDING LLC 2023-03-07 US disclosed
US-20210322785-A1 COMPOSITIONS AND METHODS FOR TREATING WOUNDS THERAGENICS CORPORATION 2021-10-21 US disclosed
EP-3893785-A1 COMPOSITIONS AND METHODS FOR TREATING WOUNDS C.P. Medical Corporation (US) 2021-10-20 EP disclosed
US-11083821-B2 Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules C.P. MEDICAL CORPORATION (US) 2021-08-10 US disclosed
CN-100425652-C High-performance reinforced fire-retardant polyster engineering plastic SUZHOU CHEMICAL NEW MATERIAL C (CN) 2008-10-15 CN disclosed
US-4201869-A Intermediates for steroid total synthesis process utilizing asymmetric induction HOFFMANN-LA ROCHE INC. (US) 1980-05-06 US disclosed
US-4102925-A 1-HYDROCARBYLAMINO-3-KETO-6-(3-ALKOXY-PHENYL)-HEXAN-6-OL, INTERMEDIATES HOFFMANN-LA ROCHE INC. (US) 1978-07-25 US disclosed
US-4092483-A Intermediates for steroid total synthesis process utilizing asymmetric induction HOFFMANN-LA ROCHE INC. (US) 1978-05-30 US disclosed
US-4011211-A RING CLOSURE, ACIDS HOFFMANN-LA ROCHE INC. (US) 1977-03-08 US disclosed
US-4003949-A 3-KETO-6-(3-ALKOXYPHENYL)-1-HEXENE-6-OL HOFFMANN-LA ROCHE INC. (US) 1977-01-18 US disclosed
US-3932519-A 7,7A-Dihydro-4-[2-(3-alkoxyphenyl)-2-hydroxyethyl]-7a-alkyl-1, 5(6H)-indandiones,3,4,8,8a-tetrahydro-5-[2-(3-alkoxyphenyl)-2-hydroxyethyl]-8a-alkyl-1,6(7H)-naphthalenediones and processes for the preparation thereof utilizing asymmetric induction HOFFMANN-LA ROCHE INC. (US) 1976-01-13 US disclosed